CNBX Pharmaceuticals Inc (CNBX)

[jim992]

Links and overviews regarding April Study & Patents:

1. April 2018 - Capsules Study Due In April 2018. I pasted a brief overview at the bottom of this post. Here is the link: https://clinicaltrials.gov/ct2/show/NCT02359123

2. January 2018 Cannabinoid International Patent Application:
https://www.prnewswire.com/news-releases/cannabics-pharmaceuticals-files-an-international-patent-application-on-methods-for-testing-and-predicting-therapeutic-effectiveness-of-cannabinoids-for-cancer-patients-667671863.html

3. November 2017 - Patent for Cannabinoid Modulation of the Microbiome: https://www.prnewswire.com/news-releases/cannabics-pharmaceuticals-files-patent-application-on-cannabinoid-modulation-of-the-microbiome-656114393.html

4. September 2017 - US Patent - Cannabics announced today it has filed an extensive provisional patent application with the US Patent & Trademark Office (USPTO) on a new Method for Sensitivity Tests of Cannabinoids on Patient-Derived Tumor Biopsies and CTCs.
https://www.thestreet.com/story/14295507/1/cannabics-pharmaceuticals-files-a-patent-application-for-sensitivity-tests-of-cannabinoids-on-patient-derived-tumor-biopsies-and-ctcs.html

5. August 2017 Positive Report Regarding Patent Application which means the patent office saw novelty of product and process:
https://www.prnewswire.com/news-releases/cannabics-pharmaceuticals-received-positive-report-from-the-patent-cooperation-treaty-regarding-cannabinoid-personalized-screening-of-cancer-cells-300510252.html

April Study Info from Link # 1: Last line shows April 2018 Completion Date:

Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 40 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Cannabics Capsules as Treatment to Improve Cancer Related Cachexia and Anorexia Syndrome in Advanced Cancer Patients- Pilot Study
Study Start Date : November 2016
Estimated Primary Completion Date : December 2017
Estimated Study Completion Date : April 2018